REMEDISC Trademark

Trademark Overview


On Thursday, February 23, 2023, a trademark application was filed for REMEDISC with the United States Patent and Trademark Office. The USPTO has given the REMEDISC trademark a serial number of 97809425. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, February 28, 2025. This trademark is owned by Spine Biopharma, LLC. The REMEDISC trademark is filed in the Pharmaceutical Products category with the following description:

Biomedical compounds, namely, amino acids for medical purposes administered for medical therapies; amino acids for medical purposes administered by injection for treatment of spinal diseases or disorders; 7-amino acid peptide chain, namely, amino acids for medical purposes administered by intradiscal injection for the treatment of lumbar degenerative disc disease.
remedisc

General Information


Serial Number97809425
Word MarkREMEDISC
Filing DateThursday, February 23, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, February 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements


Goods and ServicesBiomedical compounds, namely, amino acids for medical purposes administered for medical therapies; amino acids for medical purposes administered by injection for treatment of spinal diseases or disorders; 7-amino acid peptide chain, namely, amino acids for medical purposes administered by intradiscal injection for the treatment of lumbar degenerative disc disease.
Pseudo MarkREME DISC

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSpine Biopharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10022

Party NameSpine Biopharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10022

Trademark Events


Event DateEvent Description
Monday, February 27, 2023NEW APPLICATION ENTERED
Tuesday, November 21, 2023ASSIGNED TO EXAMINER
Wednesday, November 29, 2023NON-FINAL ACTION WRITTEN
Wednesday, November 29, 2023NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 28, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, February 28, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, March 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 28, 2025SOU TEAS EXTENSION RECEIVED
Friday, February 28, 2025SOU EXTENSION 1 FILED
Saturday, March 1, 2025SOU EXTENSION 1 GRANTED
Sunday, March 2, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER